EUVIMEDEUVIMED entdecken
Systematische Übersicht

Consensus-based guidance for the nutritional management of children with cystic fibrosis on ELEXACAFTOR/TEZACAFTOR/IVACAFTOR

Tamarah Katz, Josie van Dorst, Bernadette Prentice, Christine L Chan, Dimitri Declercq, Tanja Gonska, Jodi Grunert, Daina Kalnins, Christina N Katsagoni, Amanda Leonard, Catherine M McDonald, Paul McNally und 9 weitere

Journal of Cystic Fibrosis · 2026-07 · 25 (4) · 594-599

DOI: 10.1016/j.jcf.2026.02.004 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Journal of Cystic Fibrosis, 2026-07. Verfasst von Tamarah Katz und 20 weiteren Autor:innen. Beteiligte Einrichtung: School of Clinical Medicine, Discipline of Paediatrics and Child Health, UNSW Medicine and Health, University of New South Wales, Sydney, Australia; …. Hauptthemen laut MEDLINE: Cystic Fibrosis, Indoles, Quinolones, Aminophenols. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 6 Literaturangaben. Gefördert von: National Health and Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: The introduction of CFTR modulators such as elexacaftor/tezacaftor/ivacaftor (ETI) has significantly altered the nutritional trajectory of children with cystic fibrosis (cwCF). While most eligible children in high-resource countries have commenced ETI, the rollout has outpaced the development of nutritional guidance. This study aimed to: (1) systematically review the literature on ETI and nutrition (2) develop expert consensus-based statements and (3) highlight existing research gaps and priorities. METHODS: A systematic review and guideline development process was registered on PROSPERO (ID: CRD42024587618). An expert panel of 22 professionals, including dietitians, gastroenterologists, respirologists, endocrinologists, and a parent representative was convened with attention to global representation. Research questions were developed using the Population, Intervention, Comparison, Outcome (PICO) framework. A comprehensive literature search was conducted across Medline, Embase, CINAHL, and Cochrane (January 2010 to April 2025). Studies were independently screened, assessed for quality using Scottish Intercollegiate Guidelines Network (SIGN) criteria, and extracted into evidence tables. Draft statements were developed and refined through iterative feedback and online discussion. Final consensus was achieved using real-time Delphi, with ≥80% agreement required for endorsement. Reporting followed Accurate Consensus Reporting Document (ACCORD) guidelines. RESULTS: 67 consensus-based statements were developed. The top research priorities were identified based on the greatest proportion of "strongly agree" responses. CONCLUSION: ETI has altered nutritional requirements in cwCF, yet evidence remains limited. This study presents the first consensus-based guidance for the nutritional care of cwCF receiving ETI, providing interim, expert informed recommendations and highlighting research priorities, particularly the need to re-evaluate traditional BMI targets.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cystic FibrosisIndolesQuinolonesAminophenolsBenzodioxolesPyrrolidinesHumansChildDrug CombinationsConsensusChloride Channel AgonistsPyrazolesPyridinesQuinolines

Stichwörter der Autor:innen

ChildrenCystic FibrosisElexacaftor Tezacaftor IvacaftorNutrition

Substanzen

IndolesQuinolonesDrug CombinationsAminophenolsBenzodioxolesChloride Channel AgonistsPyrrolidineselexacaftor, ivacaftor, tezacaftor drug combinationPyrazolesPyridines

Autor:innen und Institutionen

  • School of Clinical Medicine, Discipline of Paediatrics and Child Health, UNSW Medicine and Health, University of New South Wales, Sydney, Australia; Department of Nutrition and Dietetics, Sydney Children's Hospital Netw…
  • School of Clinical Medicine, Discipline of Paediatrics and Child Health, UNSW Medicine and Health, University of New South Wales, Sydney, Australia.
  • School of Clinical Medicine, Discipline of Paediatrics and Child Health, UNSW Medicine and Health, University of New South Wales, Sydney, Australia; Department of Respiratory Medicine, Sydney Children's Hospital Network…
  • Department of Pediatrics, Section of Endocrinology, Children's Hospital Colorado, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
  • Department of Pediatrics, Cystic Fibrosis Reference Centre, Ghent University Hospital, Department of Internal Medicine and Pediatrics, Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium.
  • Pediatric Gastroenterology, Toronto Hospital for Sick Children, Toronto, ON, Canada.

Förderung

  • National Health and Medical Research Council

Zitieren

APA

Katz, T., van Dorst, J., Prentice, B., Chan, C. L., Declercq, D., Gonska, T., Grunert, J., Kalnins, D., Katsagoni, C. N., Leonard, A., McDonald, C. M., McNally, P., Mielus, M., Munck, A., Naehrlich, L., Owen, E., Smith, C., Schwarzenberg, S. J., Terlizzi, V., …, & Ooi, C. Y. (2026). Consensus-based guidance for the nutritional management of children with cystic fibrosis on ELEXACAFTOR/TEZACAFTOR/IVACAFTOR. Journal of Cystic Fibrosis, 25(4), 594-599. https://doi.org/10.1016/j.jcf.2026.02.004

Vancouver

Katz T, van Dorst J, Prentice B, Chan CL, Declercq D, Gonska T, et al. Consensus-based guidance for the nutritional management of children with cystic fibrosis on ELEXACAFTOR/TEZACAFTOR/IVACAFTOR. Journal of Cystic Fibrosis. 2026;25(4):594-599. doi:10.1016/j.jcf.2026.02.004

BibTeX
@article{Katz2026,
  author = {Katz, Tamarah and van Dorst, Josie and Prentice, Bernadette and Chan, Christine L and Declercq, Dimitri and Gonska, Tanja and Grunert, Jodi and Kalnins, Daina and Katsagoni, Christina N and Leonard, Amanda and McDonald, Catherine M and McNally, Paul and Mielus, Monika and Munck, Anne and Naehrlich, Lutz and Owen, Elizabeth and Smith, Chris and Schwarzenberg, Sarah Jane and Terlizzi, Vito and Wilschanski, Michael and Ooi, Chee Y},
  title = {Consensus-based guidance for the nutritional management of children with cystic fibrosis on ELEXACAFTOR/TEZACAFTOR/IVACAFTOR},
  journal = {Journal of Cystic Fibrosis},
  year = {2026},
  volume = {25},
  number = {4},
  pages = {594--599},
  doi = {10.1016/j.jcf.2026.02.004}
}
Kostenlos starten →